Page last updated: 2024-09-03

reboxetine and transforming growth factor beta

reboxetine has been researched along with transforming growth factor beta in 2 studies

Compound Research Comparison

Studies
(reboxetine)
Trials
(reboxetine)
Recent Studies (post-2010)
(reboxetine)
Studies
(transforming growth factor beta)
Trials
(transforming growth factor beta)
Recent Studies (post-2010) (transforming growth factor beta)
62619318449,11956017,610

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Connor, TJ; González-Reyes, RE; Griffin, EW; Harkin, A; McNamee, EN; Ryan, KJ; Ryan, KM1
Arolt, V; Cerovecki, A; Dehning, S; Müller, N; Musil, R; Riedel, M; Schwarz, MJ; Spellmann, I1

Trials

1 trial(s) available for reboxetine and transforming growth factor beta

ArticleYear
Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression--no influence of celecoxib treatment.
    Journal of affective disorders, 2011, Volume: 134, Issue:1-3

    Topics: Adult; Aged; Antidepressive Agents; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Depression; Depressive Disorder; Depressive Disorder, Major; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Humans; Intramolecular Oxidoreductases; Macrophage Migration-Inhibitory Factors; Male; Middle Aged; Morpholines; Psychiatric Status Rating Scales; Psychological Tests; Pyrazoles; Reboxetine; Sulfonamides; Transforming Growth Factor beta; Young Adult

2011

Other Studies

1 other study(ies) available for reboxetine and transforming growth factor beta

ArticleYear
Noradrenaline acting at central beta-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: implications for neurodegeneration.
    Brain, behavior, and immunity, 2010, Volume: 24, Issue:4

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Animals; Brain; Cerebral Cortex; Clenbuterol; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hippocampus; Idazoxan; Injections, Intraperitoneal; Interleukin-10; Interleukin-4; Male; Morpholines; Norepinephrine; Phosphorylation; Propranolol; Rats; Rats, Sprague-Dawley; Reboxetine; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-2; Signal Transduction; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Transforming Growth Factor beta

2010